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http://dx.doi.org/10.1016/j.stemcr.2016.07.003SUMMARYDegenerative cartilage endplate (CEP) shows decreased chondrification and increased ossification. Cartilage endplate stem cells (CESCs),
with the capacity for chondro-osteogenic differentiation, are responsible for CEP restoration. CEP is avascular and hypoxic, while the
physiological hypoxia is disrupted in the degenerated CEP. Hypoxia promoted chondrogenesis but inhibited osteogenesis in CESCs.
This tissue-specific differentiation fate of CESCs in response to hypoxia was physiologically significant with regard to CEP maintaining
chondrification and refusing ossification. MIF, a downstream target of HIF1A, is involved in cartilage and bone metabolisms, although
little is known about its regulatory role in differentiation. In CESCs, MIF was identified as a key point through which HIF1A regulated
the chondro-osteogenic differentiation. Unexpectedly, unlike the traditionally recognizedmode, increased nuclear-expressedMIF under
hypoxia was identified to act as a transcriptional regulator by interacting with the promoter of SOX9 and RUNX2. This mode of HIF1A/
MIF function may represent a target for CEP degeneration therapy.INTRODUCTION
Degenerative disc disease (DDD) is considered to be the
most important cause of low back pain (LBP), which is
one of the most common reasons for activity limitation
(Andersson, 1999). Many pathological factors account for
DDD, such as cell senescence, inflammatory factors, and
extracellular matrix degradation (Le Maitre et al., 2007;
Peng et al., 2006; Wang et al., 2015). A declining metabolic
exchange due to the accumulation of waste products and
nutrition insufficiency appears to be the most important
of these mechanisms (Buckwalter, 1995). The interverte-
bral disc (IVD) is the largest avascular organ in the human
body, and themetabolic exchange is predominantly reliant
on the diffusion effect across cartilage endplate (CEP) in the
mature IVD (Holm et al., 1981). The CEP is a thin horizon-
tal layer of hyaline cartilage that separates the IVD from the
vertebral body. Blood vessels in the adjacent vertebral
bones do not reach the inner component of the discs
but end at the interface between IVD and the vertebrae
(Raj, 2008). Because it is the most important metabolic ex-
change channel, many studies assert that the degeneration
of CEP may initiate DDD (Li et al., 2010).
Chondrification characteristics are considered to be
critical in the physiological function of CEP. Changes in
the cartilaginous biochemical content of CEP are closely
related to IVD degeneration. Thematrix of CEP is primarilyStem Cell
This is an open access article under the Ccomposed of collagen type II, which is not only necessary
for cartilage to resist compressive forces but is also instru-
mental in the transport properties of CEP. In addition,
CEP ossification reduces the solute transport, which finally
leads to DDD (Roberts et al., 1996). However, the mecha-
nisms responsible for the loss of chondrification and the
onset of ossification remain unclear.
Recent studies by our group demonstrated the presence
of stem cells in the CEP. These cartilage endplate stem cells
(CESCs) exhibited superior capacity for chondrogenic and
osteogenic differentiation to those of bone marrowmesen-
chymal stem cells (BM-MSCs) (Liu et al., 2011). This differ-
entiation property attracted our attention because it is
likely that CESCs play an important role in the restoration
and regeneration of CEP, and the direction of chondrogen-
esis and osteogenesis in CESCs may be responsible for CEP
chondrification and ossification.
As an avascular tissue, IVD remains in a hypoxic micro-
environment (Boskey, 2008), and the oxygen tension
within CEP is as low as 1% (Lee et al., 2007). Hypoxia
greatly affects the chondrogenesis and osteogenesis of
MSCs (Merceron et al., 2010), which indicates that phys-
iological hypoxia may regulate the chondro-osteogenic
differentiation of CESCs to maintain a balance of chondri-
fication and ossification in CEP.
The hypoxia-inducible factor-1a subunit/macrophage
migration inhibitory factor (HIF1A/MIF) pathway is oneReports j Vol. 7 j 249–262 j August 9, 2016 j ª 2016 The Author(s). 249
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Figure 1. DDD CEP Exposed to Less Hyp-
oxia Exhibited Less Chondrification and
More Ossification than LVF CEP
(A) Representative MRI of patients. Patients
with lumbar vertebral fracture (LVF) were
classified as grade 1, and patients with lum-
bar DDDasgrade 6 according to the Pfirrmann
classification system. The arrowheads indi-
cate the experimental material position.
(B and C) Western blot (B) and analysis
(C) of the expressions of HIF1A, COL1, and
COL2. Protein content was measured by
densitometry and normalized according to
ACTB level. The expressions of HIF1A and
COL2 were decreased but the expression of
COL1 was increased in DDD CEP compared
with LVF CEP. Data represent the mean ± SD
(n = 3 independent experiments, t test).
*p < 0.05, **p < 0.01.
(D) General observation of samples and
immunohistochemical staining in tissue
sections. Arrowheads indicate small fissures
in the DDD CEP, positively staining collagen
matrix and positively staining cells.of the most important signaling pathways in response to
hypoxia. HIF1A is a key cellular regulator in responding
to hypoxia; MIF, which has been recognized as a down-
stream target of HIF1A, acts as a regulator of innate immu-
nity and can regulate many biological activities (Fu et al.,
2010; Maity and Koumenis, 2006). MIF is highly involved
in cartilage metabolism. MIF knockdown in zebrafish em-
bryos can lead to undeveloped jaw cartilage (Ito et al.,
2008). Moreover, MIF was observed to be involved in the
degenerative process of CEP (Xiong et al., 2014). In mouse
neural progenitor cells, MIF promoted survival andmainte-
nance by upregulating the expression of SOX6, which is
also a member of the SOX family and is co-expressed
with SOX9 in all chondroprogenitors, indicating that MIF
may initiate chondrogenesis in progenitor cells (Ohta
et al., 2013). In addition, MIF was also involved in bone
metabolism (Onodera et al., 2002). Transgenic mice over-
expressing MIF exhibited osteoporosis, implying that the
overexpression ofMIFmay lead to poor osteogenesis capa-
bility (Onodera et al., 2006). Obviously, the cartilage and
bone metabolism was closely related to the chondrogenic
and osteogenic differentiation of stem cells; however, the
impact of the HIF1A/MIF pathway upon chondro-osteo-
genic differentiation is rarely reported. The transcription
factor SOX9 is the master regulator of chondrogenesis
and is expressed in pre-chondrocytes and differentiated
chondrocytes during skeletal development (Healy et al.,
1996). The transcription factor RUNX2 acts as the master
regulator of skeletogenesis; its expression is necessary
for osteoblast differentiation and maturation (Ducy et al.,250 Stem Cell Reports j Vol. 7 j 249–262 j August 9, 20161997). In this study, we investigated how the HIF1A/MIF
pathway regulated SOX9 and RUNX2, which resulted in
a change in the chondro-osteogenic differentiation fate
of CESCs.RESULTS
Degenerated CEP under Relative Normoxia Lost
Chondrification and Acquired Ossification
To understand changes in the chondrification, ossification,
and hypoxic conditions during CEP degeneration, we as-
sessed relatively normal CEP tissues in patients with lum-
bar vertebral fracture (LVF) without a formerly documented
clinical history of LBP as the undegenerated group.We also
assessed degenerated CEP tissues in patients with DDD as a
degenerated group according to the Pfirrmann classifica-
tion system (Pfirrmann et al., 2001) (Figure 1A). There
were small fissures in the CEP samples of the degenerated
group (Figure 1D). We then investigated the expression
of HIF1A, collagen type I (COL1), and collagen type II
(COL2) in human CEP from patients with LVF and DDD
using western blot (Figures 1B and 1C) and immunohisto-
chemistry (Figure 1D). The expression of HIF1A and COL2
was increased in CEP from LVF compared with those in
CEP from DDD. Conversely, the expression of COL1 was
remarkably decreased in CEP from LVF. These results
showed that the degenerated CEP had lost chondrification
and acquired ossification compared with the undegener-
ated group. In addition, HIF1A functioned as a sensor of
Figure 2. CESCs Shared Features with BM-MSCs Regarding Morphology, Stem Cell Surface Markers, and Differentiation Ability
(A) H&E staining of the tissue section.
(B) Morphology of CESCs in agarose after seeding 6 weeks later.
(C) Histologic section stained with Alcian blue of chondrified pellets in which CESCs formed in chondrogenic induction medium after
3 weeks.
(D) Alizarin red staining of CESCs that underwent osteogenic induction for 3 weeks.
(E) Immunophenotypic profile of stem cells in CESCs by flow cytometric analysis. The green lines indicate the fluorescence intensity of cells
stained with the corresponding antibodies, and the red lines represent isotype-matched negative control cells.
(F) Percentages of CESCs expressing different stem cell markers (n = 6 independent experiments). Data represent the mean ± SD.hypoxia, the robust expression of which was detected in
avascular tissue such as the nucleus pulposus in IVD (Raj-
purohit et al., 2002). The decreased expression of HIF1A
suggested that the degenerated CEP remained in a less hyp-
oxic microenvironment than the undegenerated CEP.
CESCs Exhibited Features Similar to Those of
BM-MSCs
We used H&E staining to eliminate the possibility of
pollution with other residual impurities (Figure 2A). CESCs
exhibited a typical fibroblast-like morphology and a swirl-
ing-like pattern, which was homogeneous with BM-MSCs
(Figure 2B). The multipotency of CESC differentiation
was evaluated by induction into chondrogenic (Figure 2C)
and osteogenic (Figure 2D) lineages in vitro. Cell-surface
immunophenotypes were checked by flow cytometric
analysis. Immunophenotypic evaluation showed that
CESCs were positive for stem cell markers, including
CD73, CD90, and CD105, but negative for CD14, CD19,
CD34, CD45, and HLA-DR (Figures 2E and 2F), which
met the criteria of the International Society for Cellular
Therapy (Dominici et al., 2006).HIF1A Promoted Chondrogenesis and MIF Expression
while Inhibiting Osteogenesis
HIF1A is considered the master transcriptional regulator
of cellular and developmental responses to hypoxia (Se-
menza, 2001). Dimethyloxalylglycine (DMOG), which in-
creases the endogenous level of HIF1A, has been shown
tomimic ‘‘chemical hypoxia’’ under normoxia. YC1,which
downregulates HIF1A at posttranslational level, was used in
our study to create ‘‘chemical normoxia’’ under hypoxia.
To evaluate the effect of HIF1A on chondrogenic dif-
ferentiation and osteogenic differentiation in a hypoxic
microenvironment, we induced CESCs in chondrogenic
induction medium (CIM) and osteogenic induction me-
dium (OIM) treated with PBS or DMOG under normoxia
(21% O2) and treated with PBS or YC1 under hypoxia
(1% O2).
The expression levels of SOX9 and COL2 in the nor-
moxia + DMOG group and the hypoxia + PBS group were
greater than those in the normoxia + PBS group both as
mRNA (Figure 3A) and proteins (Figures 3B and 3C).
Conversely, the expression levels of RUNX2 and COL1 in
the normoxia + DMOG group and the hypoxia + PBS groupStem Cell Reports j Vol. 7 j 249–262 j August 9, 2016 251
Figure 3. Hypoxia Increased Chondrogenic Differentiation and MIF Expression while Decreasing Osteogenic Differentiation
by HIF1A
CESCs were induced under normoxia + PBS (NP), normoxia + DMOG (ND), hypoxia + PBS (HP), and hypoxia + YC1 (HY) conditions in
chondrogenic induction medium (CIM) (A–C) or osteogenic induction medium (OIM) (D–G), respectively, for 3 weeks.
(A) Chondrogenic gene (SOX9 and COL2), HIF1A, and MIF gene expression were assessed by RT-PCR of mRNA from CESCs induced in CIM.
(B and C) Western blot analysis of the expression of SOX9, COL2, HIF1A, and MIF in samples treated under the conditions in (A). The protein
contents were normalized according to ACTB level.
(D) Osteogenic gene (RUNX2 and COL1), HIF1A, and MIF gene expression were assessed by RT-PCR of mRNA from CESCs induced in OIM.
(E and F) Western blot analysis of the expression of RUNX2, COL1, HIF1A, and MIF in samples treated under the conditions in (D). The
protein contents were normalized according to ACTB level.
(G) Macrographs of alizarin red staining and ALP staining of CESCs treated under the conditions in (D).
Data represent the mean ± SD (n = 3 independent experiments, t test). *p < 0.05, **p < 0.01, ***p < 0.001.were significantly lower than those in the normoxia + PBS
group both as mRNA (Figure 3D) and proteins (Figures 3E
and 3F). After treatment with an HIF1A inhibitor (YC1) in252 Stem Cell Reports j Vol. 7 j 249–262 j August 9, 2016a hypoxic microenvironment, the expressions of SOX9
and COL2 were markedly decreased (Figures 3A–3C),
whereas the expression of RUNX2 and COL1 were
increased compared with those in the hypoxia + PBS group
(Figures 3D–3F). HIF1A also had an inhibitory effect on
the functional mineralization of CESCs (Figure 3G). These
results revealed that HIF1A promoted chondrogenic differ-
entiation and inhibited osteogenic differentiation in a hyp-
oxic microenvironment.
After 21 days of induction, at the protein level the expres-
sions of HIF1A in the normoxia + DMOG group and the
hypoxia + PBS group were greater than those in the nor-
moxia + PBS group, and the expression of HIF1A in the
hypoxia + YC1 group was markedly decreased compared
with that in the hypoxia + PBS group (Figures 3B, 3C, 3E,
and 3F). These data implied that the method of treatment
effectively regulated HIF1A. Notably, we observed that
the expression of HIF1A at the mRNA level shared the
same trend with that at the protein level under DMOG
and hypoxia treatment, while under YC1 treatment, the
mRNA level and the protein level of HIF1A expression ex-
hibited a different trend. Thus YC1 might only regulate
HIF1A at the posttranslational stage (Figures 3A and 3D).
Previous studies showed that MIF expression was
increased in response to hypoxia (Fu et al., 2010). We initi-
ated a study to investigate MIF regulation by hypoxia
in CESCs. Our results indicated that, at both mRNA and
protein levels, MIF wasmarkedly increased when subjected
to DMOG or hypoxia compared with normoxia; YC1-
treated CESCs had significantly decreased MIF expression
in response to hypoxia. These results provided evidence
that MIF was a downstream target of HIF1A and that hyp-
oxia induced MIF expression at both mRNA and protein
levels from CESCs in an HIF1A-dependent manner.
MIF Was Responsible for HIF1A-Induced Chondro-
Osteogenic Gene Expression under Hypoxia
To determine whether HIF1A-mediated MIF contributed
to hypoxia-induced chondro-osteogenic changes, we de-
signed short hairpin RNAs (shRNAs) against MIF and a
lentiviral vector system to efficiently overexpress MIF. MIF
shRNA and scrambled shRNA vector were applied to the
normoxia + DMOG group and hypoxia + PBS group in
which MIF expression should had been relatively high.
MIF overexpression and scrambled overexpression vector
were added to the normoxia + PBS group and hypoxia +
YC1 group in whichMIF expression should have been rela-
tively low.
In CIM (Figures 4A–4C) and OIM (Figures 4D–4G), hyp-
oxia and HIF1A upregulation mediated chondrogenesis
and inhibited osteogenesis. This effect was reversed by
shRNA against MIF. Normoxia and HIF1A downregulation
mediated chondrogenesis. Osteogenesis was reversed by
the overexpression of lentivirus against MIF.
As reported previously, MIF contributed to HIF stabi-
lization by preventing proteasome-mediated degradation(Winner et al., 2007). There was a positive feedback loop
between HIF1A and MIF (Gaber et al., 2011). These were
confirmed in our experiment. At the protein level, we
observed a near-complete rescue of HIF1A expression in
MIF overexpression lentivirus-treated CESCs in a nor-
moxia + PBS group or hypoxia + YC1 group (Figures 4B
and 4C) and a nearly complete knockdown of HIF1A
expression in MIF-shRNA-treated CESCs in a normoxia +
DMOG group or hypoxia + PBS group (Figures 4E and
4F). At the transcription level, the change in MIF did not
consistently influence the expression of HIF1A; changes
in MIF varied according to the treatment system (Figures
4A and 4D). These data showed that MIF regulated HIF1A
primarily on the protein level and not the mRNA level.
These findings were consistent with previous research
(Gaber et al., 2011).
MIF Expression Was Increased in the Cell Nucleus
under Hypoxia
To detect the cellular location of MIF, we conducted an
immunofluorescence analysis after induction. Unexpect-
edly, we observed that MIF expression in the nucleus was
increased in the normoxia + DMOG and hypoxia + PBS
groups compared with the normoxia + PBS and hypoxia +
YC1 groups (Figures 5A and 5B). This phenomenon was
confirmed by western blot analysis; the ratio of MIF expres-
sion in the nucleus compared with that in cytoplasm was
greater in the normoxia + DMOG and hypoxia + PBS
groups than in the normoxia + PBS and hypoxia + YC1
groups (Figures 5C and 5D). The change in the nuclear
expression of MIF suggested of a dominant role of MIF in
the cell nucleus.
MIF Promoted SOX9 Promoter Activity and Repressed
RUNX2 Promoter Activity
Previous studies showed a unique contribution of MIF to
the transcriptional regulation of some important transcrip-
tional factors (Hudson et al., 1999; Petrenko et al., 2003;
Petrenko and Moll, 2005). We observed that MIF was re-
distributed in the nucleus under hypoxia. We then sought
to determine whether MIF played a role as a transcrip-
tional regulator in regulating the transcriptional activities
of two additional important transcription factors, SOX9
and RUNX2.
To determine whether the transcriptional activities of
SOX9 and RUNX2 were regulated by MIF during chon-
drogenesis and osteogenesis, we performed an analysis of
promoter activities with luciferase reporter assay in a
293T cell line. We chose the putative regulatory loci of
the SOX9 and RUNX2 genes (from300 bp to 0 bp) accord-
ing to previous studies (Colter et al., 2005; Hawse et al.,
2011; Kanai and Koopman, 1999; Piera-Velazquez et al.,
2007; Tamiya et al., 2008; Zhang et al., 2009). TheStem Cell Reports j Vol. 7 j 249–262 j August 9, 2016 253
Figure 4. HIF1A Regulated Chondro-Osteogenic Differentiation of CESCs by MIF
CESCs assigned to normoxia + PBS (NP) and hypoxia + YC1 (HY) groups, in which MIF expression should have been relatively low, were
transfected with MIF-overexpressing lentiviral vector system (M+) and its scramble control (Scr). CESCs assigned to normoxia + DMOG (ND)
and hypoxia + PBS (HP) groups in which MIF expression should had been relatively high were transfected with MIF-shRNA (M) and its
scramble control (Scr).
(A) SOX9, COL2, HIF1A, and MIF gene expression were assessed by RT-PCR of mRNA from CESCs induced in CIM.
(B and C) Western blot analysis of the expression of SOX9, COL2, HIF1A, and MIF in samples treated under the conditions in (A).
(D) RUNX2, COL1, HIF1A, and MIF gene expression were assessed by RT-PCR of mRNA from CESCs induced in OIM.
(E and F) Western blot analysis of the expression of RUNX2, COL1, HIF1A, and MIF in the samples treated under the conditions in (D).
(G) Macrographs of alizarin red staining and ALP staining of CESCs treated under the conditions in (D).
Data represent the mean ± SD (n = 3 independent experiments, t test). *p < 0.05, **p < 0.01, ***p < 0.001.upregulation of SOX9 and the downregulation of RUNX2
upon MIF overexpression could be due to the acquisition
of transcriptional regulation by MIF (Figure 6A).254 Stem Cell Reports j Vol. 7 j 249–262 j August 9, 2016To determine whether MIF was associated with the pro-
moter of SOX9 and RUNX2 via interaction with the recog-
nizing region demonstrated via luciferase reporter assay, we
Figure 5. MIF Expression Was Increased in the Cell Nucleus under Hypoxia
(A and B) Immunofluorescence staining of CESCs under normoxia + PBS (NP), normoxia + DMOG (ND), hypoxia + PBS (HP), and hypoxia +
YC1 (HY) conditions, respectively, in CIM (A) and OIM (B) for 3 weeks. Arrowheads indicate the nuclear MIF expression.
(legend continued on next page)
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Figure 6. MIF Regulated the Transcrip-
tion of SOX9 and RUNX2 by Interacting
with the Promoters
(A) A luciferase reporter assay showed
that overexpressing MIF regulated SOX9
and RUNX2 promoter activities. Reporter
constructs containing 300 bp to 0 bp
were constructed (n = 3 independent ex-
periments, t test).
(B and C) ChIP analysis of CESCs. The ex-
tracted chromatins were incubated with
anti-MIF antibody or isotype IgG antibody.
A 231-bp fragment in the 300 bp to 0 bp
region in the SOX9 promoter and a 195-bp
fragment in the 300 bp to 0 bp region in
the RUNX2 promoter were amplified by PCR
(B) and qRT-PCR (C). The results were
normalized to the input control (n = 3 in-
dependent experiments, t test).
Data represent the mean ± SD. **p < 0.01,
***p < 0.001.performed a chromatin immunoprecipitation (ChIP)-PCR
assay using CESCs. PCR amplification (Figure 6B) and
real-time PCR (Figure 6C) showed that a 231-bp DNA frag-
ment corresponding to a sequence from291 bp to61 bp
in the SOX9 promoter region and a 195-bp DNA fragment
corresponding to a sequence from 288 bp to 94 bp in
the RUNX2 promoter region were immunoprecipitated
with MIF antibody in CESCs. Figure 7 is a schematic dia-
gram of proposed mechanisms for HIF1A/MIF-mediated
regulatory effects on chondro-osteogenic differentiation
in CESCs.DISCUSSION
The CEP arises from embryonic mesoderm-derived
tissue, and CESCs share characteristics related to cell-sur-
face immunophenotype and the capacity to differentiate
into mesoderm-derived cells, namely osteocytes, chondro-
blasts, and adipocytes (Liu et al., 2011), CESCs are thus
considered as MSCs.
Common sources of MSCs in studies usually exist under
hypoxic conditions: bone marrow (4%–7%), adipose tissue
(3.8%–9.6%), and muscle tissue (1%–10%) (D’Ippolito
et al., 2006; Redshaw and Loughna, 2012; Schiller et al.,
2013). The tissue specificity of the differentiation of the(C) Western blot of the nuclear MIF expression (upper panels) and cyto
and cytoplasmic protein expressions were normalized by LaminB1 an
(D) Nuclear-cytoplasmic ratio of MIF, the quantitative analysis of (C
t test). *p < 0.05.
256 Stem Cell Reports j Vol. 7 j 249–262 j August 9, 2016MSCs in response to hypoxia can be observed. In BM-
MSCs, hypoxia promoted chondrogenesis and inhibited
osteogenesis and adipogenesis (Khan et al., 2010; Martin-
Rendon et al., 2007; Yang et al., 2011). Adipose-derived
MSCs tended to differentiate into adipocytes or chondro-
cytes, and the ability of osteogenic differentiation was
dwarfed under hypoxia (Kim et al., 2014; Merceron et al.,
2010). In muscle stem cells, low oxygen concentration
favored myogenic differentiation but suppressed adipo-
genic differentiation (Redshaw and Loughna, 2012). The
periodontal ligament stem cells promoted osteogenic dif-
ferentiation under hypoxia (Zhang et al., 2014). Taken
together, stem cells from different tissues show different
tissue-specific differentiation fate in the physiological hyp-
oxic microenvironment, which may facilitate the restora-
tion and regeneration function of stem cells.
To determine tissue specificity in CESC differentiation,
we performed chondrogenic and osteogenic induction
under normoxia and hypoxia, respectively. Our study re-
vealed tissue specificity indicating that hypoxia promoted
chondrogenesis but inhibited osteogenesis in CESCs. This
tissue specificity of CESC differentiation in response to
physiological hypoxia contributed to our understanding
of the mechanism of CEP degeneration in the context of
CESCs. Due to the avascular nature, in CEP the oxygen ten-
sion was as low as 1% (Lee et al., 2007). As previous studiesplasmic MIF expression (lower panels) in CIM and OIM. The nuclear
d ACTB, respectively.
). Data represent the mean ± SD (n = 3 independent experiments,
Figure 7. Schematic Diagram of Proposed Mechanisms for HIF1A/MIF-Mediated Regulatory Effects on Chondro-Osteogenic
Differentiation in CESCs
TSS, transcription start site.described, the CEP was free of blood vessels in groups of
healthy juveniles and adolescents without a history of
LBP. In adults and seniors with DDD, there were defects
in the CEP whereby blood vessel invasion could be
observed (Nerlich et al., 2007). Blood vessel invasion was
also noted in painful human IVD (Freemont et al., 2002).
In osteoarthritis, osteochondral angiogenesis within sub-
chondral spaces was often caused by the invasion of neo-
vessels that increased the oxygen level (Walsh et al.,
2010). It is reasonable to assert that, in degenerated CEP,
blood vessel invasion through small fissures accompanied
by an increased oxygen tension in the microenvironment
could disrupt the physiological hypoxic microenviron-
ment of CESCs. This destruction could inhibit CESCs
chondrogenic differentiation and facilitate osteogenic
differentiation, which could initiate the loss of chondri-
fication and the acquisition of ossification in CEP. The
ossification of CEP resulted in a poor capacity to resist me-
chanical stress and poor nutrient exchange; complete IVD
degeneration was thus initiated.Ina studyof chondro-osteogenicdifferentiation inCESCs,
we observed a critical role of HIF1A in regulating the direc-
tion of differentiation. HIF1A was a key cellular regulator
in responding to a low oxygen level (Coimbra et al., 2004).
Anumberof cartilage-related andosteogenesis-relatedgenes
were under transcriptional control by HIF1A (Robins et al.,
2005; Wagegg et al., 2012). Given this background, we
mimicked ‘‘chemical hypoxia’’ under normoxia via DMOG
upregulating the expression of HIF1A and ‘‘chemical
normoxia’’ under hypoxia by YC1 downregulating the
expression of HIF1A. We observed that the promotion of
chondrogenesis and the inhibition of osteogenesis were
directly correlated with the expression of HIF1A in CESCs.
We then investigated how HIF1A regulated chondrogen-
esis and osteogenesis. A cytokine, MIF, which had been
recognized as an important hypoxia-induced gene, was a
downstream target of HIF1A. MIF acted as a regulator of
innate immunity and could regulate many biological
activities, such as cell proliferation, senescence, and angio-
genesis. Notably, although MIF was involved in cartilageStem Cell Reports j Vol. 7 j 249–262 j August 9, 2016 257
and bone metabolism, the regulation of chondro-osteo-
genicdifferentiationbyMIFhasnotbeen studied. InCESCs,
we observed that MIF acted as a key factor in chondro-oste-
ogenic differentiation under hypoxia. Firstly, consistent
with previous research, MIF expression was induced by
hypoxia at the level of mRNA and protein in an HIF1A-
dependentmanner. Secondly,hypoxia andHIF1Amediated
changes in the ability of chondro-osteogenesis to be
reversed by MIF expression via human intervention.
The mode of action of MIF in previous studies can be
encapsulated in five aspects: (1)MIF receptor, (2) activation
of ERK1/ERK2, (3) upregulation of TLR4 expression, (4) sup-
pression of p53 activity, and (5) inhibition of JAB1 activity
(Calandra and Roger, 2003; Lue et al., 2002).We next inves-
tigated the presence of other pathways. Unexpectedly, in
CESCs an increased nuclear MIF expression under hypoxia
was observed. As previous studies described, a high nuclear
expression of MIF could also be observed in the tissues of
lung adenocarcinoma, glioblastoma multiforme, pituitary
adenoma, and aggressive bladder cancer (Kamimura et al.,
2000; Markert et al., 2001; Pyle et al., 2003; Taylor et al.,
2007); the samewas observed in our study usingCESCs. Tu-
mor tissue is veryhypoxic, andwe speculated that increased
nuclearMIF expressionmay occur in this hypoxicmicroen-
vironment. MIF may not act in the traditional manner but
may play a biological role in the nucleus. After the analysis
of the three-dimensional structure of MIF, we considered
that MIF might lack a typical DNA-binding motif. In this
study, ChIP showed the potential interaction between
MIF and the promoter regions of SOX9 and RUNX2, leading
us to conclude thatMIF could bind toDNA indirectly via in-
termediate proteins. From the result of the luciferase report,
we observed that MIF could participate in the regulation of
transcription. Based on the above information, we think
that MIF could act as a ‘‘transcriptional regulator’’ that par-
ticipates in the regulation of transcription indirectly, but
not as a ‘‘transcription factor’’ that functions viadirect bind-
ing to DNA sequences. A limitation of this study is that the
intermediate mechanism has not been fully investigated.
Further studies are required to illuminate this mechanism.
Noticeably, the redistribution of protein from the cyto-
plasm to the nucleus was observed inmany regulatorymol-
ecules, such as nuclear factor kB (Haddad, 2009) and AKT
(Xuan et al., 2006). We thus speculated that the increased
nuclear MIF in hypoxic tumors may interact with the tran-
scription factors responsible for cell growth, apoptosis, and
angiogenesis in a manner similar to that of MIF regulating
SOX9 and RUNX2 in CESCs.
In conclusion, this work firstly explained the clinical
pathological phenomenon by which degenerative CEP
decreased chondrification and increased ossification. The
change in the differentiation fate of CESCs in response
to disrupted physiological hypoxia could represent the258 Stem Cell Reports j Vol. 7 j 249–262 j August 9, 2016cytological basis of CEP degeneration, whichwould initiate
the degeneration of the entire IVD at a later stage. The
maintenance of tissue specificity in stem cells depended
on a subtle balance in the microenvironment, whereby
some key cytokines played decisive roles in determining
the function of stem cells. In CEP, the differentiation fate
of CESCs was determined by the hypoxic microenviron-
ment. Secondly, the study showed that MIF exhibited
an important regulating function in the chondro-osteo-
genic differentiation fate of stem cells. Thirdly, unlike the
traditionally recognized mode, a regulatory HIF1A/MIF
pathway in which MIF acted as a transcriptional regulator
in the nucleus was observed in CESCs under hypoxia,
which represents an attractive target for therapeuticmodal-
ities to treat degeneration. In addition, the HIF1A/MIF
pathway played crucial roles in cell proliferation (Gaber
et al., 2011), senescence (Maity and Koumenis, 2006) and
angiogenesis (Chesney et al., 1999) in the hypoxic tissue,
especially in tumors. Whether these biological processes
were also regulated by this mode warrants further study.EXPERIMENTAL PROCEDURES
Patients and Subjects
TheCEP tissues used in this studywere obtained frompatientswho
underwent discectomy and fusion operations at the Xinqiao Hos-
pital of the Third Military Medical University (see also Table S1).
The relatively normal human CEP control tissues were obtained
from three patients with LVF without a history of LBP. The degen-
erated CEP were obtained from six patients with DDD. The state of
IVD degeneration was evaluated according to the Pfirrmann classi-
fication system (Pfirrmann et al., 2001). The study procedures were
approved by the Ethics Committee of Xinqiao Hospital, ThirdMil-
itary Medical University and were in accordance with the Helsinki
Declaration, and written informed consent was obtained from
each patient.Lentivirus
MIF shRNA lentiviral particles (Santa Cruz Biotechnology,
sc-37137-V) and scrambled shRNA lentiviral particles (Santa
Cruz, sc-108080) were purchased for the knockdown of MIF
expression (accession no. Genbank: NM_002415.1). MIF overex-
pression lentivirus (on vector pLenti6.3_MCS_IRES2-EGFP, Invi-
trogen) and a scrambled vector were packed by Invitrogen.Tissue Procurement
The surgically explanted CEP were cleaned of any adherent tissues
and washed with 0.1 M sterile PBS. A small portion of CEP tissue
was saved for H&E staining to eliminate the possibility of pollution
of any other residual impurity.Immunohistochemistry and Histology
The CEP specimens were freshly collected in the operating room,
fixed immediately in 4% formalin for 12 hr, and dehydrated
through 40% sucrose solutions for 48 hr. Sections were cut to 5-mm
thickness, put onto glass slides, and dried for 3 hr. The slides
for staining were blocked for endogenous peroxidase activity using
3%H2O2 solution for 5min. They were then blockedwith 3% goat
serum, incubated in rabbit anti-human HIF1A antibody (Abcam,
ab85886), mouse anti-human COL1 antibody (Abcam, ab90395),
and rabbit anti-human COL2 antibody (Abcam, ab34712), respec-
tively, overnight at 4C, washed three times in PBS, and incubated
in the corresponding secondary antibody (anti-rabbit immuno-
globulin-horseradish peroxidase [IgG-HRP]-linked antibody, Cell
Signaling Technology, #7074; anti-mouse IgG-HRP-linked anti-
body, Cell Signaling, #7076) for 1 hr with washing three times in
PBS. Immunoreactive proteins were revealed with nickel-diamino-
benzidine. Images were obtained with a microscope.CESC Isolation and Culture
The CEP samples were mechanically minced and digested with
0.2% collagenase II (Sigma-Aldrich) in DMEM/F12 medium
(Hyclone) containing 1% fetal calf serum (FCS; Gibco) for
12 hr at 37C. The suspended cells were then filtered through a
70-mm cell filter. The suspension was centrifuged for 5 min at
1,000 rpm/min. After removing the suspension solution, the pellet
was resuspended with culture medium containing DMEM/F12,
10% FCS, and 1% penicillin-streptomycin (Hyclone). Finally, the
cells were cultured in a 25-cm2 cell-culture flask at 37C and 5%
CO2 condition. After the first passage of expansion, cells were
cultured in agarose solution. The agarose selection system was es-
tablished as previously described (Liu et al., 2011). In brief, culture
dishes were coated with 1% low-melting-point agarose (Invitro-
gen). Then a mixture of 0.5 mL of DMEM/F12 medium, 0.5 mL
of 2% low-melting-point agarose, and 1 mL of culture medium
with 53 104 CEP cells was added to the culture dishes. The culture
dishes were then transferred in a humidified atmosphere with 5%
CO2 at 37
C. The culture medium was changed twice per week.
After 6 weeks, cell aggregates were aspirated with a sterile Pasteur
pipette and cultured in a 25-cm2 cell-culture flask. Passage 3 cells
were used in this study.Flow Cytometry
CESCs were trypsinized and washed in PBS and stained with the
following conjugated antibodies: mouse anti-human CD14-FITC
(eBioscience, 11-0149-41), mouse anti-human CD19-FITC (eBio-
science, 11-0199-41), mouse anti-humanCD34-FITC (eBioscience,
11-0349-41), mouse anti-human CD45-FITC (eBioscience, 11-
9459-41), mouse anti-human CD73-FITC (eBioscience, 11-0739-
41), mouse anti-human CD90-FITC (eBioscience, 11-0909-41),
mouse anti-human CD105-PE (eBioscience, 12-1057-41), mouse
anti-human HLA-DR-PerCP-Cyanine 5.5 (eBioscience, 45-9956-
41). IgG (mouse IgG1 kappa isotype control-FITC, eBioscience,
11-4714-81; mouse IgG1 kappa isotype control-PE, eBioscience,
12-4714-41; mouse IgG2b kappa isotype control-PerCP-Cyanine
5.5, eBioscience, 45-4732-80) were used as isotype control. The
final antibody concentrationwas at 1mg/200mL. After incubating
for 30 min at 37C, the cells were washed three times with PBS.
Finally, labeled CESCs were subjected to flow cytometry analysis,
and the percentage of positive staining was calculated relative to
the isotype control staining.Induction and Oxygen Deprivation
For chondrogenic or osteogenic differentiation, cells were induced
in CIM (Cyagen) or OIM (Cyagen). For hypoxic culture, CESCs
were cultured in a 1% O2 condition or treated in medium contain-
ing 100 mM HIF1A inducer (DMOG; Sigma-Aldrich) in normoxic
conditions (21% O2). For normoxic culture, CESCs were cultured
in normoxic conditions (21%O2) or treated inmedium containing
100 mM HIF1A inhibitor (YC1; Sigma-Aldrich) in hypoxic condi-
tions (1% O2). The induction medium was changed twice per
week over a 21-day period.
Alizarin Red and ALP Staining
For identification of themineral deposits after OIM induction, cells
were fixed for 30 min with 4% paraformaldehyde (PFA), washed
three times in PBS, and stained with alizarin red (Cyagen) for
5 min and then washed three times in PBS. For alkaline phospha-
tase (ALP) staining, the cells were fixedwith 4%PFA for 30min and
stained with an alkaline phosphatase assay kit (Beyotime) accord-
ing to the manufacturer’s instructions, then washed three times
with PBS. The stained cultures were photographed.
qRT-PCR
RNA was purified via Trizol extraction (Invitrogen). The RNA
was transcribed into cDNA with a PrimeScript RT Master Mix Kit
(TaKaRa). The primers were designed to amplify 100–250-bp-sized
products (see also Table S2). The ABI 7900H Real-Time PCR system
and the SYBR Premix Ex Taq II (TaKaRa) were used for qRT-PCR.
The qPCR reactions were incubated at 95C for 30 s followed
by 40 cycles of 95C for 5 s and 60C for 34 s and a dissociation
curve analysis. The expressions of each gene were normalized to
Actin-beta (ACTB) expression.
Western Blot
Western cell lysis buffer (Beyotime) was used for the extraction
of total protein. Nuclear and cytoplasmic protein extraction kits
(Beyotime) were used for the extraction of nuclear and cytoplasmic
proteins, respectively. Protein extraction was performed according
to themanufacturer’s instructions. Proteinconcentrationwasdeter-
mined using the BCA kit (Beyotime). Approximately 30 mg of pro-
tein from each sample was diluted in PBS and 53 loading buffer
was boiled for 5 min, separated via SDS-PAGE (Willget Biotech),
and transferred to a polyvinylidene fluoride membrane (Bio-Rad).
The tailored membranes were incubated with the corresponding
primary antibodies (rabbit anti-human ACTB, Abcam, ab8227; rab-
bit anti-human anti-LaminB1, Abcam, ab65986; rabbit anti-human
SOX9, Abcam, ab3697; rabbit anti-humanCOL2, Abcam, ab34712;
rabbit anti-human RUNX2, Cell Signaling, #12556; mouse anti-
humanCOL1, Abcam, ab90395; rabbit anti-humanHIF1A, Abcam,
ab85886; rabbit anti-human MIF, Abcam, ab175189), respectively,
overnight at 4C, washed three times in PBS, and incubated in the
corresponding secondary antibody (anti-rabbit IgG-HRP-linked
antibody, Cell Signaling, #7074; anti-mouse IgG-HRP-linked anti-
body, Cell Signaling, #7076) for 1 hr with washing three times in
PBS, then subjected to western blotting using a Pierce ECL western
blotting substrate kit (Thermo Scientific). Immunoreactive proteins
weremeasured by chemiluminescent detection. The expressions of
proteins were normalized to the ACTB level.Stem Cell Reports j Vol. 7 j 249–262 j August 9, 2016 259
Immunofluorescence
Cells were reseeded in cell-culture dishes. After induction, the cells
were fixed in 4% PFA and treated with a blocking solution contain-
ing 1% goat serum and 0.5% Triton X-100. The cells were stained
with rabbit anti-human MIF antibody (Abcam, ab175189) over-
night at 4C. The cells were then washed three times with PBS and
incubated with FITC-conjugated goat anti-rabbit IgG secondary
antibody (Invitrogen, A24532) for 1 hr at room temperature. Subse-
quently, cell nucleiwere stainedwith 0.1mg/mLDAPI (Invitrogen).
The stained cells were examined with a confocal microscope.
Luciferase Assay
Genomic DNA from 293T cells was used to amplify the 300 bp
to 0 bp fragment of the human SOX9 and RUNX2 promoter
region, which was cloned into the pGL3-basic vector (Promega)
using HindIII and SmaI sites (primers listed in Table S2). The
reporter gene constructs were co-transfected into 293T cells
with MIF-overexpressing plasmids and scramble control plasmids
using Lipofectamine 2000 reagent (Invitrogen). Renilla luciferase
plasmid (Promega) was used as a normalized control with Lipofect-
amine 2000. Firefly and Renilla luciferase activities were measured
consecutively with the dual luciferase assay kit (Promega) 48 hr
after transfection.
Chromatin Immunoprecipitation
CESCs were crosslinked with 1% formaldehyde for 20 min at 37C
and sonicated. The DNA-protein mixture was then isolated with a
ChIP assay kit (Millipore) according to the manufacturer’s instruc-
tions with rabbit anti-human MIF antibody (Abcam, ab175189).
The precipitated DNA was quantified using RT-PCR with primers
listed in Table S2. The results were normalized according to the
input control.
Statistical Analyses
The data are expressed as the mean ± SD of independent experi-
ments. Comparisons weremade using independent-samples t tests
when comparing two experimental groups. Significance values
were set at a p value of <0.05.
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